Episode Details

Weight Loss Drugs: A Growing Controversy as Cities and States Cut Coverage

Cities and states are reconsidering coverage for weight loss drugs like Ozempic and Wegovy, citing rising costs and demand. Obesity rates have dropped, but twelve percent of adults now use these meds. California, New Hampshire, Pennsylvania, and South Carolina have ended Medicaid coverage, while others limit it or consider restrictions. Doctors and lawmakers argue that cuts may lead to worse health issues down the line. Some propose subscription deals with drug makers, but theyre not biting due to high demand. Prices are expected to fall as competition increases, but the real question is whether states will prioritize short-term savings or long-term health investments.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/9aa72db802c5505c